References
- Italian multicenter breast study with epirubicin. Phase III randomized study of fluorouracil. epirubicin, and cyclophosphamide vs fluorouracil, doxorubicin, and cyclophosphamide in advanced breast cancer: An Italian multicentre trial. J Clin Oncol 1988; 6: 976–982
- The French Epirubicin Study Group: A prospective randomized phase III trial comparing combination chemotherapy with cyclophosphamide, fluorouracil, and either doxorubicin or epirubicin?. J Clin Oncol. 1988; 6: 679–688
- Hernadi Z, Juhasz B, Pokar A, et al. Randomised trial comparing combinations of cyclophosphamide and cisplatin without or with doxorubicin or 4'epi-adriamycin in the treatment of advanced ovarian cancer. Int J Gynecol Obst 1988; 27: 199–204
- Wils J, Blijham G, Naus A, et al. Primary or delayed debulking surgery and chemotherapy consisting of cisplatin, doxorubicin, and cyclophosphamide in stage III-IV epithelial ovarian carcinoma?. J Clin Oncol. 1986; 4: 1068–1073
- Wils J. Long-term follow-up of patients with advanced ovarian carcinoma treated with debulking surgery and Chemotherapy consisting of cisplatin, doxorubicin. and cyclophosphamide. Oncology 1990; 47: 115–120
- Ten Bokkel Huinink WW. Current status of chemotherapy fur advanced ovarian carcinoma?. Eur J Cancer Clin Oncol. 1988; 24: 583–585
- The Ovarian Cancer Meta-Analysis Project: Cyclophosphamide plus cisplatin versus cyclophosphamide, doxorubicin, and cisplatin chemotherapy of ovarian carcinoma; a meta-analysis?. J Clin Oncol. 1991; 9: 1668–1674
- Neijt JP, ten Bokkel Huinink WW, van der Burg MEL, et al. Randomized trial comparing two combination chemotherapy regimens (CHAP-5 v CP) in advanced ovarian carcinoma. J Clin Oncol 1987; 5: 1157–1168